Price T Rowe Associates Inc Alkermes Plc. Transaction History

Price T Rowe Associates Inc

$816 Billion
Q1 2024

A detailed history of Price T Rowe Associates Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 8,326,256 shares of ALKS stock, worth $195 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

8,326,256

Previous 1,595,585 421.83%

Holding current value

$195 Million

Previous $44.3 Million 409.22%

% of portfolio

0.03%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$26.4 - $32.56 $178 Million - $219 Million	6,730,671 Added 421.83%	8,326,256 $225 Million
Q4 2023 Feb 14, 2024	BUY	$23.37 - $28.68 $1.76 Million - $2.15 Million	75,100 Added 4.94%	1,595,585 $44.3 Million
Q3 2023 Nov 14, 2023	BUY	$27.17 - $31.97 $299,929 - $352,916	11,039 Added 0.73%	1,520,485 $42.6 Million
Q2 2023 Aug 14, 2023	SELL	$28.34 - $33.63 $960,867 - $1.14 Million	-33,905 Reduced 2.2%	1,509,446 $47.2 Million
Q1 2023 May 15, 2023	SELL	$25.31 - $29.02 $682,408 - $782,437	-26,962 Reduced 1.72%	1,543,351 $43.5 Million

Q4 2022 Feb 14, 2023	SELL	$21.94 - $26.24 $68.4 Million - $81.8 Million	-3,116,858 Reduced 66.5%	1,570,313 $41 Million
Q3 2022 Nov 14, 2022	SELL	$22.0 - $31.87 $127 Million - $183 Million	-5,752,767 Reduced 55.1%	4,687,171 $105 Million
Q2 2022 Aug 15, 2022	SELL	$26.4 - $30.54 $279 Million - $323 Million	-10,560,157 Reduced 50.29%	10,439,938 $311 Million
Q1 2022 May 16, 2022	SELL	$23.07 - $27.99 $7.92 Million - $9.61 Million	-343,486 Reduced 1.61%	21,000,095 $553 Million
Q4 2021 Feb 14, 2022	BUY	$21.47 - $32.08 $1.66 Million - $2.48 Million	77,340 Added 0.36%	21,343,581 $496 Million
Q3 2021 Nov 15, 2021	SELL	$23.37 - $32.13 $36.9 Million - $50.7 Million	-1,578,713 Reduced 6.91%	21,266,241 $656 Million
Q2 2021 Aug 16, 2021	SELL	$18.78 - $25.15 $17.1 Million - $22.9 Million	-909,684 Reduced 3.83%	22,844,954 $560 Million
Q1 2021 May 17, 2021	BUY	$18.21 - $23.2 $3.24 Million - $4.12 Million	177,736 Added 0.75%	23,754,638 $444 Million
Q4 2020 Feb 16, 2021	BUY	$15.39 - $22.1 $363 Million - $521 Million	23,576,902 New	23,576,902 $470 Million

Others Institutions Holding ALKS

# of Institutions

358

Shares Held

180M

Call Options Held

522K

Put Options Held

463K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $3.84B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Alkermes Plc. Transaction History